Mysthenia gravis is an autoimmune neuromuscular disease caused by antibodies blocking or reducing acetylcholine receptors at the neuromuscular junction, resulting in fluctuating muscle weakness that worsens with activity and improves with rest. It can affect any muscle and occur at any age or gender. Symptoms may include ptosis, difficulty swallowing or speaking, and weakness of facial or eye muscles. Diagnosis involves testing for acetylcholine receptor antibodies and imaging for potential thymoma. Treatment options include acetylcholinesterase inhibitors to increase acetylcholine levels, immunosuppressants to reduce antibody levels, plasma exchange to remove antibodies, and immunoglobulins for crisis situations.